Unlike leukemia, activation of ABL kinases in solid tumors is not linked to chromosomal translocation events, but is rather characterized by their enhanced expression and activation due to amplification, increased gene or protein expression, or increased activity in response to stimulation by oncogenic tyrosine kinase and chemokine receptors, oxidative stress, and metabolic stress [13]. This evidence concerns the gene ABL1 and leukemia.